Lake Street Private Wealth LLC Has $2.66 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Lake Street Private Wealth LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 257.8% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,084 shares of the healthcare conglomerate's stock after purchasing an additional 3,663 shares during the period. Lake Street Private Wealth LLC's holdings in UnitedHealth Group were worth $2,663,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Financial Management Professionals Inc. increased its holdings in UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares during the last quarter. Richwood Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares during the last quarter. Global Wealth Strategies & Associates lifted its stake in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after purchasing an additional 20 shares during the last quarter. Prentice Wealth Management LLC increased its position in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock worth $1,278,000 after buying an additional 21 shares during the last quarter. Finally, 44 Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.6% in the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock worth $662,000 after buying an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.33% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. Oppenheimer reduced their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a report on Monday, May 19th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Barclays lowered their price target on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research report on Monday. Finally, Piper Sandler decreased their target price on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $428.43.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $7.40 during mid-day trading on Friday, reaching $303.24. 12,558,756 shares of the stock were exchanged, compared to its average volume of 6,976,622. The company has a market cap of $275.08 billion, a price-to-earnings ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50-day simple moving average of $413.43 and a 200 day simple moving average of $486.09.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the firm earned $6.91 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.92%. UnitedHealth Group's dividend payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.